Reduction in membrane component of diffusing capacity is associated with the extent of acute pulmonary embolism

Päivi Piirilä1, Mia Laiho, Pirjo Mustonen

  • 1Department of Clinical Physiology, HUSLAB, Helsinki University Central Hospital, Finland. paivi.piirila@hus.fi

Insights

Acute pulmonary embolism (PE) significantly reduces diffusing capacity of the alveolo-capillary membrane (DM) and pulmonary diffusing capacity for carbon monoxide (DL,CO). These reductions persist long-term, primarily due to DM impairment, even after treatment.

Area of Science:

  • Pulmonary Medicine
  • Cardiopulmonary Physiology

Background:

  • Acute pulmonary embolism (PE) is known to impair pulmonary diffusing capacity for carbon monoxide (DL,CO).
  • The precise mechanisms and long-term consequences of this impairment, particularly concerning the diffusing capacity of the alveolo-capillary membrane (DM) and pulmonary capillary blood volume (Vc), remain incompletely understood.

Purpose of the Study:

  • To investigate the association between the extent of PE, right ventricular dysfunction (RVD), and reductions in DM and Vc.
  • To assess the recovery of these parameters 7 months after acute PE.

Main Methods:

  • Spiral computed tomography (CT) to assess PE extent.
  • Single-breath method using carbon monoxide and oxygen to measure DL,CO, Vc, DM, and alveolar volume (VA).
  • Transthoracic echocardiography and electrocardiogram for RVD evaluation.

Main Results:

  • Patients with acute PE exhibited significantly lower DL,CO, DM, and vital capacity (VC) compared to healthy controls.
  • DM showed an inverse correlation with the central mass of embolism.
  • Despite significant improvements within 7 months, DM and DL,CO remained lower than in controls, especially in patients with persistent RVD.

Conclusions:

  • Reduction in DM is the primary driver of sustained DL,CO decrease in PE patients after 7 months.
  • The extent of PE and RVD severity influence the impairment of DM and DL,CO.
  • Long-term follow-up reveals persistent deficits in diffusing capacity despite treatment.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
External and Internal Respiration01:24

External and Internal Respiration

External respiration occurs in the lungs, and it is the first step in the journey of oxygen inside the body. When we inhale, oxygen enters our lungs and diffuses across the thin alveolar membrane. The alveoli are tiny, air-filled sacs that provide a vast surface area for gas exchange. Oxygen in the alveoli has a higher partial pressure (105 mmHg) than in the adjacent pulmonary capillaries (40 mmHg), establishing a pressure gradient. As a result, oxygen molecules move from the alveoli into the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.